FOCL
Price
$4.67
Change
+$0.09 (+1.96%)
Updated
Sep 25, 04:59 PM (EDT)
Capitalization
216.72M
Intraday BUY SELL Signals
SENS
Price
$10.00
Change
-$0.34 (-3.29%)
Updated
Sep 25, 04:59 PM (EDT)
Capitalization
546.72M
46 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

FOCL vs SENS

FOCL vs SENS Comparison Chart in %
View a ticker or compare two or three
VS
FOCL vs. SENS commentary
Sep 26, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FOCL is a Hold and SENS is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
FOCL vs SENS: Fundamental Ratings
FOCL
SENS
OUTLOOK RATING
1..100
7641
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
53
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
3836
P/E GROWTH RATING
1..100
9923
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SENS's Valuation (53) in the Electronic Components industry is somewhat better than the same rating for FOCL (100) in the Biotechnology industry. This means that SENS’s stock grew somewhat faster than FOCL’s over the last 12 months.

SENS's Profit vs Risk Rating (100) in the Electronic Components industry is in the same range as FOCL (100) in the Biotechnology industry. This means that SENS’s stock grew similarly to FOCL’s over the last 12 months.

SENS's SMR Rating (99) in the Electronic Components industry is in the same range as FOCL (100) in the Biotechnology industry. This means that SENS’s stock grew similarly to FOCL’s over the last 12 months.

SENS's Price Growth Rating (36) in the Electronic Components industry is in the same range as FOCL (38) in the Biotechnology industry. This means that SENS’s stock grew similarly to FOCL’s over the last 12 months.

SENS's P/E Growth Rating (23) in the Electronic Components industry is significantly better than the same rating for FOCL (99) in the Biotechnology industry. This means that SENS’s stock grew significantly faster than FOCL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FOCLSENS
RSI
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 4 days ago
81%
Declines
ODDS (%)
Bearish Trend 10 days ago
85%
Bearish Trend 17 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
60%
COMPARISON
Comparison
Sep 26, 2026
Stock price -- (FOCL: $4.59 vs. SENS: $10.34)
Brand notoriety: FOCL and SENS are both not notable
FOCL represents the Medical Distributors, while SENS is part of the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: FOCL: 30% vs. SENS: 118%
Market capitalization -- FOCL: $216.72M vs. SENS: $546.72M
FOCL [@Medical Distributors] is valued at $216.72M. SENS’s [@Medical/Nursing Services] market capitalization is $546.72M. The market cap for tickers in the [@Medical Distributors] industry ranges from $44.8K to $101.36B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $174.89B. The average market capitalization across the [@Medical Distributors] industry is $22.4B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FOCL’s FA Score shows that 0 FA rating(s) are green while SENS’s FA Score has 1 green FA rating(s).

  • FOCL’s FA Score: 0 green, 5 red.
  • SENS’s FA Score: 1 green, 4 red.
According to our system of comparison, SENS is a better buy in the long-term than FOCL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FOCL’s TA Score shows that 4 TA indicator(s) are bullish while SENS’s TA Score has 6 bullish TA indicator(s).

  • FOCL’s TA Score: 4 bullish, 4 bearish.
  • SENS’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, SENS is a better buy in the short-term than FOCL.

Price Growth

FOCL (@Medical Distributors) experienced а +7.24% price change this week, while SENS (@Medical/Nursing Services) price change was +9.65% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +0.28%. For the same industry, the average monthly price growth was -8.78%, and the average quarterly price growth was -19.93%.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.03%. For the same industry, the average monthly price growth was -8.43%, and the average quarterly price growth was +2.00%.

Reported Earning Dates

SENS is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Medical Distributors (+0.28% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

@Medical/Nursing Services (-2.03% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
FOCL
Daily Signal:
Gain/Loss:
SENS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
AVS8.250.11
+1.30%
Direxion Daily AVGO Bear 1X ETF (AVS)
VDE175.420.67
+0.38%
Vanguard Energy ETF (VDE)
PRNT24.91-0.07
-0.27%
3D Printing ETF (PRNT)
XJR48.79-0.14
-0.29%
iShares ESG Select Screened S&P Small-Cap ETF (XJR)
DBJP115.81-0.94
-0.80%
Xtrackers MSCI Japan Hedged Equity ETF (DBJP)

FOCL and

Correlation & Price change

A.I.dvisor tells us that FOCL and AORT have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FOCL and AORT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FOCL
1D Price
Change %
FOCL100%
-3.16%
AORT - FOCL
29%
Poorly correlated
-2.12%
UFPT - FOCL
20%
Poorly correlated
+3.86%
SENS - FOCL
20%
Poorly correlated
+3.66%
STXS - FOCL
16%
Poorly correlated
-2.27%
HBIO - FOCL
11%
Poorly correlated
-0.37%
More

SENS and

Correlation & Price change

A.I.dvisor indicates that over the last year, SENS has been loosely correlated with RCEL. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if SENS jumps, then RCEL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SENS
1D Price
Change %
SENS100%
+3.66%
RCEL - SENS
40%
Loosely correlated
+5.75%
QSI - SENS
39%
Loosely correlated
+3.47%
CERS - SENS
35%
Loosely correlated
+0.38%
VIVO - SENS
32%
Poorly correlated
+5.31%
MBOT - SENS
30%
Poorly correlated
N/A
More